BACKGROUND: Ovarian cancer (OVCA) is the third most common gynaecological malignancy worldwide. Long non-coding RNA (LncRNA) HCP5 and polypyrimidine tract binding protein 1 (PTBP1) involved in regulating tumors, however, with undefined mechanism in OVCA. METHODS: After validating lentiviral transfection efficiency, OVCA mouse models were constructed by intraperitoneal injection of ID8-Luc cells for 8 weeks, with sh-lncRNA HCP5, oe-PTBP1, and ferroptosis agonist Erastin treatment. In vivo imaging, tumor metastasis, immunohistochemistry, HE, and TUNEL staining were performed. Human ovarian adenocarcinoma cell SKOV3 cells underwent the same grouping. Interaction between lncRNA HCP5 and PTBP1 was examined using RNA immunoprecipitation and RNA pull-down assay. CCK8, flow cytometry, transmission electron microscopy, biochemical kits, qRT-PCR, and Western blot were performed. RESULTS: In OVCA mice, sh-lncRNA HCP5 inhibited tumor growth and increased tumor tissue pathological damage and apoptosis, with lower PTBP1, Ki67, and B-cell lymphoma-2 (Bcl-2) expression, and higher Bcl-2 associated X and caspase-3 expression. Meanwhile, sh-lncRNA HCP5 induced ferroptosis, with reduced glutathione peroxidase 4, glutathione, and recombinant solute carrier family 7, member 11 expression, and elevated malondialdehyde, lipid peroxides, 4-hydroxynonenoic acid, acyl-CoA synthetase long chain family member 4, and transferrin receptor protein expression. These effects were reversed by oe-PTBP1, and Erastin weakened the pro-tumor role of oe-PTBP1, which were also observed in SKOV3 cells. Additionally, in vitro, lncRNA HCP5 was confirmed to bind to PTBP1, and sh-lncRNA HCP5 reduced cell viability and enhanced reactive oxygen species. CONCLUSION: LncRNA HCP5 may promote OVCA progression by inhibiting ferroptosis through interaction with PTBP1, providing new targets in OVCA treatment.
Long non-coding RNA HCP5 accelerated malignant progression of ovarian cancer by inhibiting ferroptosis through interaction with polypyrimidine tract binding protein 1.
阅读:1
作者:Chen Xiaoli, Ren Qing, Zheng Xiaoyu, Shen Qifeng, Shou Jian
| 期刊: | Journal of Ovarian Research | 影响因子: | 4.200 |
| 时间: | 2025 | 起止号: | 2025 Nov 19; 18(1):271 |
| doi: | 10.1186/s13048-025-01861-6 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
